Scharnagl, H; Kannenkeril, D; Stojakovic, T; Silbernagel, G; Bosch, A; März, W; Schmieder, R.
EFFECT OF PCSK9 INHIBITION WITH EVOLOCUMAB ON THE CONCENTRATION AND COMPOSITION OF LDL SUBFRACTIONS IN HIGH-RISK PATIENTS WITH CARDIOVASCULAR DISEASE
ATHEROSCLEROSIS. 2023; 379: S71-S71.
[Poster]
Web of Science
FullText